IMMX - Balance Sheet - Immix Biopharma, Inc.

Current Liabilities	8.69 M
Accounts Payable	5.39 M
Short-Term Debt	65.2 K
Other Current Liabilities	3.23 M
Non-Current Liabilities	1.01 M
Long-Term Debt	1.01 M
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	17.7	17.5	13.4	17.6	0.4	0.7
Short Term Investments	0	0	0	0	0	0
Receivables	0	1.2	0.3	25.7 K	0.1	0.2
Inventory	0	0	0	0	0	0
Other Current Assets	2.5	1.1	1.2	0.5	13.7 K	23.5 K
Total Current Assets	20.2	19.8	14.9	18.2	0.5	0.9
PP&E	2.7	50.2 K	3.56 K	5.7 K	7.36 K	9.68 K
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0
Other Long Term Assets	20.4 K	87.2 K	6.72 K	0	0	0
Other Assets	0	0	0	0	0	0
Total Assets	22.9	19.9	14.9	18.2	0.5	0.9
LIABILITIES
Accounts Payable	5.4	1.4	0.1	0.1	0.3	0.2
Short Term Debt	65.2 K	0	0	50 K	4.1	4.1
Other Current Liabilities	3.2	2.3	1.1	9.1 K	0.9	0.2
Total Current Liabilities	8.7	3.7	1.3	0.2	5.3	4.6
Long Term Debt	1.0	0	0	0	0	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	0	0	0.5	0	0	0
Total Liabilities	9.7	3.7	1.7	0.2	5.3	4.6
EQUITY
Common Stock	2.76 K	2 K	1.4 K	1.32 K	338	338
Retained Earnings	(75.0)	(53.4)	(38.0)	(29.8)	(5.4)	(4.2)
Other Accumulative Comprehensive Income/Loss	1.06 K	0.1	87 K	0.1	0.1	68.2 K
Total Equity	13.3	16.2	13.2	18.0	(4.7)	(3.6)
Total Liabilities and Equity	22.9	19.9	14.9	18.2	0.5	0.9
SHARES OUTSTANDING
Common Shares Outstanding	28.3	17.3	13.2	13.2	7.8	3.4

Free